PubMed

Differential effects of rosiglitazone on skeletal muscle and liver insulin resistance in A-ZIP/F-1 fatless mice.

Kim JK, Fillmore JJ, Gavrilova O, Chao L, Higashimori T, Choi H, Kim HJ, Yu C, Chen Y, Qu X, Haluzik M, Reitman ML, Shulman GI.

Diabetes. 2003 Jun;52(6):1311-8.PMID: 12765938 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.

Kramer D, Shapiro R, Adler A, Bush E, Rondinone CM.

Metabolism. 2001 Nov;50(11):1294-300.PMID: 11699047 [PubMed - indexed for MEDLINE]Related articles

Rosiglitazone improves muscle insulin sensitivity, irrespective of increased triglyceride content, in ob/ob mice.

Muurling M, Mensink RP, Pijl H, Romijn JA, Havekes LM, Voshol PJ.

Metabolism. 2003 Aug;52(8):1078-83.PMID: 12898477 [PubMed - indexed for MEDLINE]Related articles

Mechanism of insulin resistance in A-ZIP/F-1 fatless mice.

Kim JK, Gavrilova O, Chen Y, Reitman ML, Shulman GI.

J Biol Chem. 2000 Mar 24;275(12):8456-60.PMID: 10722680 [PubMed - indexed for MEDLINE]Related articlesFree article

The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes.

Mayerson AB, Hundal RS, Dufour S, Lebon V, Befroy D, Cline GW, Enocksson S, Inzucchi SE, Shulman GI, Petersen KF.

Diabetes. 2002 Mar;51(3):797-802.PMID: 11872682 [PubMed - indexed for MEDLINE]Related articlesFree article

Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo.

Kim HJ, Higashimori T, Park SY, Choi H, Dong J, Kim YJ, Noh HL, Cho YR, Cline G, Kim YB, Kim JK.

Diabetes. 2004 Apr;53(4):1060-7.PMID: 15047622 [PubMed - indexed for MEDLINE]Related articlesFree article

Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.

Oakes ND, Thalén PG, Jacinto SM, Ljung B.

Diabetes. 2001 May;50(5):1158-65.PMID: 11334421 [PubMed - indexed for MEDLINE]Related articlesFree article

Tissue-specific effects of rosiglitazone and exercise in the treatment of lipid-induced insulin resistance.

Lessard SJ, Rivas DA, Chen ZP, Bonen A, Febbraio MA, Reeder DW, Kemp BE, Yaspelkis BB 3rd, Hawley JA.

Diabetes. 2007 Jul;56(7):1856-64. Epub 2007 Apr 17.PMID: 17440174 [PubMed - indexed for MEDLINE]Related articlesFree article

Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance.

Kim JK, Fillmore JJ, Chen Y, Yu C, Moore IK, Pypaert M, Lutz EP, Kako Y, Velez-Carrasco W, Goldberg IJ, Breslow JL, Shulman GI.

Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7522-7. Epub 2001 Jun 5.PMID: 11390966 [PubMed - indexed for MEDLINE]Related articlesFree article

Rosiglitazone ameliorates abnormal expression and activity of protein tyrosine phosphatase 1B in the skeletal muscle of fat-fed, streptozotocin-treated diabetic rats.

Wu Y, Ouyang JP, Wu K, Wang SS, Wen CY, Xia ZY.

Br J Pharmacol. 2005 Sep;146(2):234-43.PMID: 15997237 [PubMed - indexed for MEDLINE]Related articlesFree article

Hormone-sensitive lipase knockout mice have increased hepatic insulin sensitivity and are protected from short-term diet-induced insulin resistance in skeletal muscle and heart.

Park SY, Kim HJ, Wang S, Higashimori T, Dong J, Kim YJ, Cline G, Li H, Prentki M, Shulman GI, Mitchell GA, Kim JK.

Am J Physiol Endocrinol Metab. 2005 Jul;289(1):E30-9. Epub 2005 Feb 8.PMID: 15701680 [PubMed - indexed for MEDLINE]Related articlesFree article

WY14,643, a peroxisome proliferator-activated receptor alpha (PPARalpha ) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP/F-1 mice.

Chou CJ, Haluzik M, Gregory C, Dietz KR, Vinson C, Gavrilova O, Reitman ML.

J Biol Chem. 2002 Jul 5;277(27):24484-9. Epub 2002 May 6.PMID: 11994294 [PubMed - indexed for MEDLINE]Related articlesFree article

Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.

Liu LF, Purushotham A, Wendel AA, Belury MA.

Am J Physiol Gastrointest Liver Physiol. 2007 Jun;292(6):G1671-82. Epub 2007 Feb 22.PMID: 17322064 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes.

Tiikkainen M, Häkkinen AM, Korsheninnikova E, Nyman T, Mäkimattila S, Yki-Järvinen H.

Diabetes. 2004 Aug;53(8):2169-76.PMID: 15277403 [PubMed - indexed for MEDLINE]Related articlesFree article

Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes.

Hällsten K, Virtanen KA, Lönnqvist F, Sipilä H, Oksanen A, Viljanen T, Rönnemaa T, Viikari J, Knuuti J, Nuutila P.

Diabetes. 2002 Dec;51(12):3479-85.PMID: 12453903 [PubMed - indexed for MEDLINE]Related articlesFree article

Rosiglitazone, insulin treatment, and fasting correct defective activation of protein kinase C-zeta/lambda by insulin in vastus lateralis muscles and adipocytes of diabetic rats.

Kanoh Y, Bandyopadhyay G, Sajan MP, Standaert ML, Farese RV.

Endocrinology. 2001 Apr;142(4):1595-605.PMID: 11250941 [PubMed - indexed for MEDLINE]Related articlesFree article

Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling in skeletal muscle but causes insulin resistance in liver and other tissues.

Wang H, Knaub LA, Jensen DR, Young Jung D, Hong EG, Ko HJ, Coates AM, Goldberg IJ, de la Houssaye BA, Janssen RC, McCurdy CE, Rahman SM, Soo Choi C, Shulman GI, Kim JK, Friedman JE, Eckel RH.

Diabetes. 2009 Jan;58(1):116-24. Epub 2008 Oct 24.PMID: 18952837 [PubMed - indexed for MEDLINE]Related articlesFree article

Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients.

Miyazaki Y, He H, Mandarino LJ, DeFronzo RA.

Diabetes. 2003 Aug;52(8):1943-50.PMID: 12882909 [PubMed - indexed for MEDLINE]Related articlesFree article

Topiramate is an insulin-sensitizing compound in vivo with direct effects on adipocytes in female ZDF rats.

Wilkes JJ, Nelson E, Osborne M, Demarest KT, Olefsky JM.

Am J Physiol Endocrinol Metab. 2005 Mar;288(3):E617-24. Epub 2004 Nov 9.PMID: 15536205 [PubMed - indexed for MEDLINE]Related articlesFree article

Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones.

Chao L, Marcus-Samuels B, Mason MM, Moitra J, Vinson C, Arioglu E, Gavrilova O, Reitman ML.

J Clin Invest. 2000 Nov;106(10):1221-8.PMID: 11086023 [PubMed - indexed for MEDLINE]Related articlesFree article